Zobrazeno 1 - 10
of 223
pro vyhledávání: '"Hanping Wang"'
Autor:
Chengpei Zhu, Yunchao Wang, Ruijuan Zhu, Shanshan Wang, Jingnan Xue, Dongya Zhang, Zhou Lan, Chenchen Zhang, Yajun Liang, Nan Zhang, Ziyu Xun, Longhao Zhang, Cong Ning, Xu Yang, Jiashuo Chao, Junyu Long, Xiaobo Yang, Hanping Wang, Xinting Sang, Xianzhi Jiang, Haitao Zhao
Publikováno v:
Biomarker Research, Vol 12, Iss 1, Pp 1-16 (2024)
Abstract Background Accumulating evidence suggests that the gut microbiota and metabolites can modulate tumor responses to immunotherapy; however, limited data has been reported on biliary tract cancer (BTC). This study used metagenomics and metabolo
Externí odkaz:
https://doaj.org/article/2f4d512a2fa84cf9b124ce9859b81304
Autor:
Longhao Zhang, Shanshan Wang, Yajun Liang, Xiaobo Yang, Haitao Zhao, Xinting Sang, Dongya Zhang, Zhou Lan, Hanping Wang, Ziyu Xun, Chenchen Zhang, Chengpei Zhu, Jiashuo Chao, Zilun Pu, Cong Ning, Xianzhi Jiang
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 6 (2024)
Background The association between gut bacteria and the response to immune checkpoint inhibitors (ICI) in hepatocellular carcinoma (HCC) has been studied; however, multi-kingdom gut microbiome alterations and interactions in ICI-treated HCC cohorts a
Externí odkaz:
https://doaj.org/article/ecd15d05f5644e09b41e04765b556c13
Autor:
Nan Zhang, Xu Yang, Mingjian Piao, Ziyu Xun, Yunchao Wang, Cong Ning, Xinmu Zhang, Longhao Zhang, Yanyu Wang, Shanshan Wang, Jiashuo Chao, Zhenhui Lu, Xiaobo Yang, Hanping Wang, Haitao Zhao
Publikováno v:
Biomarker Research, Vol 12, Iss 1, Pp 1-22 (2024)
Abstract Systemic therapies using programmed death-1 (PD-1) and programmed death ligand 1 (PD-L1) inhibitors have demonstrated commendable efficacy in some patients with advanced hepatocellular carcinoma (HCC); however, other individuals do not respo
Externí odkaz:
https://doaj.org/article/a79bfe8e5e4c47b2b9a876ec1ee87865
Autor:
Xiaoyan Si, Xueqing Zheng, Xinlun Tian, Hanping Wang, Yan Xu, Jing Zhao, Minjiang Chen, Wei Zhong, Mengzhao Wang, Li Zhang, Xiaotong Zhang
Publikováno v:
Thoracic Cancer, Vol 14, Iss 21, Pp 2038-2044 (2023)
Abstract Background The discovery of immune checkpoint inhibitors (ICIs) is a breakthrough in the field of cancer therapy. However, ICIs may cause immune‐related adverse reactions, including checkpoint inhibitor‐related pneumonitis (CIP). The aim
Externí odkaz:
https://doaj.org/article/ec91e25e49c948a4ab5d9abb42e1647e
Publikováno v:
Thoracic Cancer, Vol 14, Iss 13, Pp 1162-1170 (2023)
Abstract Background The c‐MET protein, encoded by the mesenchymal‐epithelial transition factor (MET) gene, can regulate cell proliferation, migration and invasion. Studies have shown that it is one of the essential driver genes for non‐small ce
Externí odkaz:
https://doaj.org/article/6db5f277803549c4ad1ab36ac70aff15
Autor:
Zhiyong Yue, Shanhong He, Jinpei Wang, Qi Jiang, Hanping Wang, Jia Wu, Chenxi Li, Zixian Wang, Xuan He, Nannan Jia
Publikováno v:
Heliyon, Vol 9, Iss 11, Pp e21874- (2023)
Flavonoids are a highly abundant class of secondary metabolites present in plants. Isoflavonoids, in particular, are primarily synthesized in leguminous plants within the subfamily Papilionoideae. Numerous reports have established the favorable role
Externí odkaz:
https://doaj.org/article/ba5386afa14646efbda1dee267155e57
Autor:
Jing Zhao, Yang Wu, Yuan Yue, Minjiang Chen, Yan Xu, Xiangning Liu, Xiaoyan Liu, Xiaoxing Gao, Hanping Wang, Xiaoyan Si, Wei Zhong, Xiaotong Zhang, Li Zhang, Mengzhao Wang
Publikováno v:
Thoracic Cancer, Vol 14, Iss 5, Pp 497-505 (2023)
Abstract Background Immune checkpoint inhibitors (ICIs) have become one important therapeutic strategy for advanced non‐small‐cell lung cancer (NSCLC). It remains imperative to identify reliable and convenient biomarkers to predict both the effic
Externí odkaz:
https://doaj.org/article/56b3c9c16b634f28bb0a279bd5b01767
Publikováno v:
Cancer Pathogenesis and Therapy, Vol 1, Iss 1, Pp 18-24 (2023)
Background: Small cell lung cancer (SCLC) is a highly malignant and aggressive neuroendocrine tumor. With the rise of immunotherapy, it has provided a new direction for SCLC. However, due to the lack of prognostic biomarkers, the median overall survi
Externí odkaz:
https://doaj.org/article/5a70c272c0294401856d3fe75b8a153f
Autor:
Puyuan Xing, Qian Zhao, Li Zhang, Hanping Wang, Dingzhi Huang, Pei Hu, Yinghui Sun, Yuankai Shi
Publikováno v:
BMC Medicine, Vol 20, Iss 1, Pp 1-15 (2022)
Abstract Background Conteltinib (CT-707) is a potent second-generation anaplastic lymphoma kinase (ALK) tyrosine kinase inhibitor (TKI) showing promising anti-tumor activities in preclinical studies. This study aimed to assess the safety, pharmacokin
Externí odkaz:
https://doaj.org/article/64d5e5dcceb64e9da3e07fa212a806ff
Autor:
Yangyang Wang, Jihan Wang, Ya Hu, Jingbo Shangguan, Qiying Song, Jing Xu, Hanping Wang, Mengju Xue, Liping Wang, Yuanyuan Zhang
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-9 (2022)
Abstract Gastric cancer (GC) is the fifth most common cancer and the third leading cause of cancer death worldwide. Discovery of diagnostic biomarkers prompts the early detection of GC. In this study, we used limma method combined with joint mutual i
Externí odkaz:
https://doaj.org/article/e1748878cab0428b87f03d617dd1a94c